myMatrixx President, Mike Cirillo, and Chief Clinical Officer, Phil Walls, were recently quoted in an article for the Workers’ Compensation Institute (WCI). Due to the COVID-19 pandemic, WCI will be holding its annual conference virtually this year and are highlighting the sponsors, including myMatrixx, in a series of posts. In the article, entitled “Clinical Vigilance and Robust Data Analysis are Keys to Delivering Reduced Workers’ Comp Drug Spend,” Cirillo and Walls share their thoughts on some of the current trends in the workers’ comp. PBM industry.
The post comes after the recent release of the 2019 myMatrixx Drug Trend Report, and the two leaders draw on many of the facts and figures it contains. Cirillo and Walls both stressed throughout that a dedication to clinical innovation and deep data analysis are essential to PBMs being able to achieve a dual mission of delivering both high quality of care and reducing spend for clients. You can read the full post here to learn more.